Mark Munger

7.1k total citations
75 papers, 1.3k citations indexed

About

Mark Munger is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark Munger has authored 75 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 10 papers in Geriatrics and Gerontology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark Munger's work include Heart Failure Treatment and Management (25 papers), Cardiovascular Function and Risk Factors (11 papers) and Blood Pressure and Hypertension Studies (11 papers). Mark Munger is often cited by papers focused on Heart Failure Treatment and Management (25 papers), Cardiovascular Function and Risk Factors (11 papers) and Blood Pressure and Hypertension Studies (11 papers). Mark Munger collaborates with scholars based in United States, Canada and Poland. Mark Munger's co-authors include Edward M. Gilbert, Karleen S. Callahan, Barbara Johnson, Ina J. Amber, Deborah Keefe, Lynette R. Moser, Gregory J. Stoddard, Curt G. Beckwith, Waymon Drummond and Mojdeh Maboudian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Mark Munger

74 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Munger United States	20	770	272	157	131	125	75	1.3k
Sheryl L. Chow United States	16	758 1.0×	179 0.7×	134 0.9×	195 1.5×	184 1.5×	43	1.3k
GT McInnes United Kingdom	14	801 1.0×	264 1.0×	111 0.7×	241 1.8×	128 1.0×	53	1.6k
G A MacGregor United Kingdom	14	776 1.0×	313 1.2×	114 0.7×	226 1.7×	152 1.2×	41	1.4k
Carlos Escobar Spain	22	1.4k 1.9×	404 1.5×	106 0.7×	279 2.1×	64 0.5×	199	2.0k
Christiano Argano Italy	19	466 0.6×	257 0.9×	130 0.8×	121 0.9×	170 1.4×	62	1.3k
Paula T. Einhorn United States	17	910 1.2×	311 1.1×	49 0.3×	161 1.2×	94 0.8×	37	1.2k
Pernille Buch Denmark	12	1.2k 1.6×	286 1.1×	101 0.6×	334 2.5×	192 1.5×	14	1.9k
Emily Atkins Australia	16	804 1.0×	224 0.8×	52 0.3×	216 1.6×	99 0.8×	69	1.4k
Luca Degli Esposti Italy	20	540 0.7×	318 1.2×	80 0.5×	299 2.3×	151 1.2×	200	1.7k
Maria-Chiara Corti Italy	8	346 0.4×	248 0.9×	98 0.6×	261 2.0×	78 0.6×	8	1.2k

Countries citing papers authored by Mark Munger

Since Specialization

Citations

This map shows the geographic impact of Mark Munger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Munger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Munger more than expected).

Fields of papers citing papers by Mark Munger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Munger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Munger. The network helps show where Mark Munger may publish in the future.

Co-authorship network of co-authors of Mark Munger

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Munger. A scholar is included among the top collaborators of Mark Munger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Munger. Mark Munger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Kibum, et al.. (2024). Riluzole Mitigates The Risk Of Heart Failure Admissions. Journal of Cardiac Failure. 30(1). 164–164.

Sundwall, David N., Mark Munger, Casey Tak, Mike Walsh, & Michael Feehan. (2020). Lifetime Prevalence and Correlates of Patient-Perceived Medical Errors Experienced in the U.S. Ambulatory Setting: A Population-Based Study. Health Equity. 4(1). 430–437. 2 indexed citations

Kim, Kibum, et al.. (2019). Understanding patients’ care barriers in the treatment of venous thromboembolism. Journal of Thrombosis and Thrombolysis. 48(1). 35–41. 2 indexed citations

Bress, Adam P., John A. Dodson, Jordan B. King, et al.. (2018). Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris. The American Journal of Cardiology. 122(11). 1809–1816. 1 indexed citations

Desbiens, Louis‐Charles, Roth‐Visal Ung, Catherine Fortier, et al.. (2018). FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study. Osteoporosis International. 29(10). 2345–2353. 21 indexed citations

Munger, Mark, Scott D. Nelson, Chia‐Chen Teng, Adam P. Bress, & Brian C. Sauer. (2017). REDUCED RISK OF NSAID INDUCED ADVERSE EVENTS WITH CONCOMITANT USE OF MISOPROSTOL. Journal of the American College of Cardiology. 69(11). 1759–1759. 1 indexed citations

Zebrack, James S., et al.. (2009). β‐Receptor Selectivity of Carvedilol and Metoprolol Succinate in Patients with Heart Failure (SELECT Trial): A Randomized Dose‐Ranging Trial. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(8). 883–890. 12 indexed citations

MacGregor, John F., et al.. (2009). Carvedilol Produces Sustained Long‐Term Benefits: Follow‐Up at 12 Years. Congestive Heart Failure. 15(1). 5–8. 8 indexed citations

Tassell, Benjamín W. Van, et al.. (2008). Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: Evidence of improved vascular α1-adrenoreceptor signal transduction. American Heart Journal. 156(2). 315–321. 10 indexed citations

10.

Munger, Mark, et al.. (2008). Safety of Prescribing PDE-5 Inhibitors via e-Medicine vs Traditional Medicine. Mayo Clinic Proceedings. 83(8). 890–896. 10 indexed citations

11.

Munger, Mark, et al.. (2003). Epidemiology and practice patterns of acute decompensated heart failure. American Journal of Health-System Pharmacy. 60(suppl_4). S3–S6. 7 indexed citations

12.

Steinberg, Earl P., et al.. (2000). The impact of the new HEDIS guidelines: Practical considerations. The American Journal of Managed Care. 6. 3 indexed citations

13.

Munger, Mark & Kai I. Cheang. (2000). β‐Blocker Therapy: A Standard of Care for Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(11P2). 359S–367S. 7 indexed citations

14.

Havranek, Edward P., Ignatius Thomas, William Smith, et al.. (1999). Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure. Journal of the American College of Cardiology. 33(5). 1174–1181. 49 indexed citations

15.

Gottlieb, Stephen S., et al.. (1996). Hemodynamic effects of the class III antiarrhythmic drug, d-sotalol, in patients with congestive heart failure. The American Journal of Cardiology. 78(12). 1411–1415. 12 indexed citations

16.

Munger, Mark, Barbara Johnson, Ina J. Amber, Karleen S. Callahan, & Edward M. Gilbert. (1996). Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 77(9). 723–727. 204 indexed citations

17.

Moser, Lynette R., Edward A. Panacek, & Mark Munger. (1996). Fatality Due to Intravenous Diltiazem for Acute Ventricular Rate Control. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(2). 306–310. 3 indexed citations

18.

Moser, Lynette R., et al.. (1994). Presence of azithromycin breast milk concentrations: A case report. American Journal of Obstetrics and Gynecology. 170(5). 1375–1376. 32 indexed citations

19.

Rutherford, William F., Edward A. Panacek, Jeffrey A. Green, et al.. (1989). Prediction of changing cerebral blood flow by use of the conjunctival oxygen tension/arterial oxygen tension index. Critical Care Medicine. 17(12). 1328–1332. 4 indexed citations

20.

Munger, Mark. (1970). Use of angiotensin receptor blockers in cardiovascular protection. Current evidence and future directions. SHILAP Revista de lepidopterología. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact